The aim of this study is to elucidate the effects of interleukin-6 (IL-6) on the expression and activity of the epithelial sodium channel (ENaC), which is one of the key mechanisms underlying tubular sodium reabsorption. M-1 cortical collecting duct cells were treated with IL-6 (100 ng/ml) for 12 h. Real-time polymerase chain reaction and immunoblotting were employed to examine the mRNA and protein abundance. Transepithelial voltage (V te) and resistance (Rte) were measured with an ohm/ voltmeter (EVOM, WPI). The equivalent current was calculated as the ratio of V te to Rte. Treatment with IL-6 (n ϭ 5) increased the mRNA abundance of ␣-ENaC by 11 Ϯ 7% (P ϭ not significant), -ENaC by 78 Ϯ 14% (P ϭ 0.01), ␥-ENaC by 185 Ϯ 38% (P ϭ 0.02), and prostasin by 29 Ϯ 5% (P ϭ 0.01), all normalized by -actin. Treatment with IL-6 increased the protein expression of ␣-ENaC by 19 Ϯ 3% (P ϭ 0.001), -ENaC by 89 Ϯ 21% (P ϭ 0.01), ␥-ENaC by 36 Ϯ 12% (P ϭ 0.02), and prostasin by 33 Ϯ 6% (P ϭ 0.02). The amiloride-sensitive sodium current increased by 37 Ϯ 5%, from 6.0 Ϯ 0.4 to 8.2 Ϯ 0.3 A/cm 2 (P Ͻ 0.01), in the cells treated with IL-6 compared with controls (P ϭ 0.01). Aprotinin (28 g/ml), a prostasin inhibitor, reduced the amiloride-sensitive sodium current by 61 Ϯ 5%, from 6.1 Ϯ 0.3 to 3.7 Ϯ 0.2 A/cm 2 (P ϭ 0.01). The magnitude of the IL-6-induced amiloride-sensitive sodium current in the presence of aprotinin dropped by 57 Ϯ 2%, from 8.6 Ϯ 0.2 to 4.9 Ϯ 0.2